New radiation patch implanted during surgery aims to stop sarcoma from coming back
NCT ID NCT04033081
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a device called CivaSheet, a permanent radiation patch placed inside the body during surgery to kill any remaining sarcoma cells. About 100 people with sarcoma in the abdomen, pelvis, or trunk will be followed for 5 years to see how safe it is and whether it helps prevent the cancer from returning. The main focus is on serious side effects and how well the radiation targets the right area.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CivaSheet (a permanent radiation implant placed during surgery to target leftover cancer cells)
What this could lead to
If successful, this could provide a new way to reduce sarcoma recurrence after surgery by delivering targeted radiation directly to the tumor bed.
What could go wrong
This is a single-arm registry, not a randomized trial, so it cannot prove the device is better than standard care. Risks include radiation-related side effects and the need for additional surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States